Pharmacoeconomic Model Adaptation

This study is basically based on determining the resource use (specialist, consultation, intensive care, hospitalization, laboratory and diagnostic tools, drug and care) for disease and adverse event management during the use of the molecule/drug in question in the relevant indication. For the validation of this study conducted with the determined physician(s), a final study is conducted with another physician experienced in the use of the molecule/drug in question. Micro-models are prepared for disease and adverse event management and the validated resource use figures are costed with current Health Implementation Communiqué prices.

The global model is updated with the local data and costs obtained, and the analyses and safety tests required for the Türkiye adaptation are performed. Finally, the final Turkish report of the model adaptation and the text and attachments to be placed in Section III of the reimbursement file are prepared.